Common Contracts
2 similar null contracts by Elixir Pharmaceuticals, Inc.
EX-10.27 6 dex1027.htm WARRANT AGREEMENT BETWEEN CENTAGENETIX & COMERICA BANKCalifornia • May 5th, 2020
THIS WARRANT AND THE SHARES OF CAPITAL STOCK ISSUABLE UPON ANY EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY STATE SECURITIES LAWS. NO SALE OR OTHER TRANSFER OF THIS WARRANT OR ANY SUCH SHARES OF CAPITAL STOCK MAY BE EFFECTED WITHOUT (i) A REGISTRATION STATEMENT RELATED THERETO SHALL BE EFFECTIVE UNDER THE ACT AND ANY APPLICABLE STATE “BLUE SKY” LAWS, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 4.2 OF THIS WARRANT.
WARRANT TO PURCHASE STOCKElixir Pharmaceuticals, Inc. • October 25th, 2007 • Pharmaceutical preparations • California
THIS WARRANT CERTIFIES THAT, in consideration of the covenants set forth in the Loan and Security Agreement between CENTAGENETIX, INC. (the “Company”) and COMERICA BANK - CALIFORNIA or its assignee (“Holder”) of even date herewith, which constitutes good and valuable consideration the receipt of which is hereby acknowledged, Holder is entitled to purchase the number of fully paid and nonassessable shares of the class of securities (the “Shares”) of Centagenetix, Inc. (the “Company”) at the initial exercise price per Share (the “Warrant Price”) all as set forth above and as adjusted pursuant to Article 2 of this warrant, subject to the provisions and upon the terms and conditions set forth in this warrant.
